ENVALITH
株式会社メディックス logo

Medix Inc.

331AStandard MarketServices

株式会社メディックス logo
Medix Inc.331A

Governance

The company operates as a Company with an Audit and Supervisory Committee, with a Board of Directors consisting of 6 members (including 3 outside directors). The Board of Directors met 29 times during the year, achieving a 100% attendance rate for all members. A voluntary Nomination and Compensation Committee (chaired by an outside director) has been established to ensure independence and objectivity.

Outside Director Ratio

50.0%

Nomination Committee

Established

Compensation Committee

Established

Risk Management

The Risk and Compliance Committee meets quarterly based on the

Shareholder Returns

Dividend per share for FY2026 (ending March 2026) is ¥18 (total dividends of ¥138 million, payout ratio 32.1%). The forecast for FY2027 (ending March 2027) is ¥19 (payout ratio 34.0%). The company repurchased 500,000 treasury shares during the period (¥257 million).

Dividend Policy

The basic policy is to continue stable and sustainable dividends while securing internal reserves to support future stable corporate growth and respond to changes in the business environment. For FY2026 (ending March 2026), the dividend is ¥18 per share (total dividends of ¥138 million, payout ratio 32.1%). The forecast for FY2027 (ending March 2027) is ¥19 per share (interim ¥8, year-end ¥11, payout ratio 34.0%).

Dividend

Paying

Share Buyback

Possible

Shareholder Benefits

None

ESG

The company positions sustainability issues as important management priorities and manages sustainability-related risks through its Risk and Compliance Committee. It recognizes human capital as a source of value creation and treats securing and developing talent as a key priority, though specific human capital metrics have not yet been established and are planned to be formulated going forward.

Last updated: June 25, 2026